SCHEMBL18476010

SCHEMBL18476010

CN(C)CC(=O)N1CCNCCNCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA9 Q16790 1/20 0.42
CHKA P35790 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
CHRNB3 Q05901 1/20 0.39
CHRNA6 Q15825 1/20 0.39
GAA P10253 1/20 0.39
TPSAB1 Q15661 1/20 0.39
TPSD1 Q9BZJ3 1/20 0.39
TPSG1 Q9NRR2 1/20 0.39
GNAI3 P08754 4/20 0.37
GNAO1 P09471 4/20 0.37
GNAI1 P63096 4/20 0.37
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188200 0.98 CA2 (0.43) CA2CA12CA1CA9CHKA
Hydrochloric Acid SCHEMBL3636826 0.96 CA2 (0.42) CA2CA12CA1CA9CHKA
Hydrochloric Acid SCHEMBL30171799 0.96 CA2 (0.42) CA2CA12CA1CA9CHKA
SCHEMBL20458954 0.91 CA2 (0.46) CA2CA12CA1CA9CHKA
Trifluoroacetic Acid SCHEMBL27188793 0.86 PKM (0.43) CA2CA12CA1CA9CHKA
Trifluoroacetic Acid SCHEMBL22123169 0.86 PKM (0.43) CA2CA12CA1CA9CHKA
Tert-Butyl Formate SCHEMBL28785798 0.81 GAA (0.40) CA2CA12CA1CA9CHKA
SCHEMBL25170359 0.81 CA2 (0.39) CA2CA12CA1CA9CHKA
SCHEMBL11948185 0.79 ATM (0.44) KDM4EGAAITGB3ITGA2B
SCHEMBL4630504 0.79 ATM (0.50) KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170035886-A1 AMPHIPHILIC DERIVATIVES OF TRIAZAMACROCYCLIC COMPOUNDS, PRODUCTS AND COMPOSITIONS INCLUDING SAME, AND SYNTHESIS METHODS AND USES THEREOF BIOCELLCHALLENGE (FR) 2017-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170035886-A1 AMPHIPHILIC DERIVATIVES OF TRIAZAMACROCYCLIC COMPOUNDS, PRODUCTS AND COMPOSITIONS INCLUDING SAME, AND SYNTHESIS METHODS AND USES THEREOF ABCB4, SLC47A2, SLC47A1 CA2 1286/4885CA12 623/4885CA1 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.